Role of NO in goat basal cerebral circulation and after vasodilatation to hypercapnia or brief ischemias.

The role of nitric oxide (NO) in the cerebral circulation under basal conditions and after vasodilatation to hypercapnia or reactive hyperemias was studied in 17 anesthetized goats. The intravenous administration of NG-nitro-L-arginine methyl ester (L-NAME, 3-4 or 8-10 mg/kg), an inhibitor of nitric oxide production, reduced middle cerebral artery (MCA) flow (electromagnetically measured) by 19 and 30% and increased systemic arterial pressure by 21 and 26%, respectively, whereas heart rate did not significantly change; MCA resistance increased by 48 and 86%, respectively. These hemodynamic effects were reversed by L-arginine (200-300 mg/kg iv; 5 goats). Different levels of hypercapnia (PCO2 of 30-35, 40-45, and 55-65 mmHg) (12 goats) produced arterial PCO2-dependent increases in MCA flow that were similar under control and L-NAME treatment. Graded cerebral hyperemia occurred after 5, 10, and 20 s of MCA occlusion in 5 goats, but its magnitude was decreased during L-NAME treatment. It suggests that, in the cerebral circulation, nitric oxide 1) produces a basal vasodilator tone and 2) is probably not involved in the vasodilatation to hypercapnia but may mediate hyperemic responses after short brain ischemias.

[1]  W. Rosenblum Endothelium‐Derived Relaxing Factor in Brain Blood Vessels Is Not Nitric Oxide , 1992, Stroke.

[2]  C. Iadecola,et al.  Does nitric oxide mediate the increases in cerebral blood flow elicited by hypercapnia? , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Kozniewska,et al.  Effects of Endothelium-Derived Nitric Oxide on Cerebral Circulation during Normoxia and Hypoxia in the Rat , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  K. Schror,et al.  Nitric Oxide Is the Endothelium‐Derived Relaxing Factor in Bovine Pial Arterioles , 1990, Stroke.

[5]  S. Moncada,et al.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo , 1990, British journal of pharmacology.

[6]  F. Faraci Role of nitric oxide in regulation of basilar artery tone in vivo. , 1990, The American journal of physiology.

[7]  D. Harrison,et al.  Evidence for an Astrocyte‐Derived Vasorelaxing Factor with Properties Similar to Nitric Oxide , 1990, Journal of neurochemistry.

[8]  A. Gibson,et al.  l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro , 1990, British journal of pharmacology.

[9]  P. Vanhoutte,et al.  Endothelium‐derived relaxing and contracting factors , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  H. Kontos,et al.  In vivo bioassay of endothelium-derived relaxing factor. , 1988, The American journal of physiology.

[11]  L. Ignarro,et al.  Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. , 1986, The Journal of pharmacology and experimental therapeutics.

[12]  W. Rosenblum Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles. , 1986, Stroke.

[13]  R. Lehman,et al.  Selective hemoglobin inhibition of endothelium-dependent vasodilation of rabbit basilar artery. , 1986, Journal of neurosurgery.

[14]  T. J. Lee Direct evidence against acetylcholine as the dilator transmitter in the cat cerebral artery. , 1980, European journal of pharmacology.

[15]  P. Daniel,et al.  Studies of the carotid rete and its associated arteries , 1953, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.

[16]  D. Heistad,et al.  Characteristics of reactive hyperemia in the cerebral circulation. , 1984, The American journal of physiology.